Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of ciprofibrate on myocardial insulin sensitivity in pre-diabetes
2018-001663-22Phase 4Completed
- Sponsor
- Maastricht University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ciprofibrate in prediabetes, insulin resistance (IR), type 2 diabetes mellitus (T2DM), heart failure (HF), sponsored by Maastricht University. Started Aug 2018; status: completed.
02
Drugs
ciprofibrate
03
Conditions
prediabetesinsulin resistance (IR)type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on 2018-001663-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001663-22.